Geron (GERN) Profit After Tax (2010 - 2026)
Geron recorded quarterly Profit After Tax of -$3.6 million in Q1 2026, up 87.38% quarter-over-quarter from -$28.9 million in Q4 2025, and up 81.64% year-over-year from -$2.0 million in Q1 2025.
Geron's Profit After Tax history runs 17 years deep, the most recent figure standing at -$3.6 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 81.64% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at -$67.3 million (up 51.58% YoY), while the FY2025 annual figure was -$83.5 million, up 52.17% from the prior year.
- Profit After Tax came in at -$3.6 million for Q1 2026 at Geron, up from -$28.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$3.6 million in Q1 2026 to a low of -$67.4 million in Q2 2024.
- A 5-year average of -$34.6 million and a median of -$30.1 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 75.08% in 2023 and soared 81.64% in 2026, its largest moves.
- Geron's Profit After Tax stood at -$42.6 million in 2022, then fell by 21.9% to -$52.0 million in 2023, then jumped by 51.22% to -$25.4 million in 2024, then retreated by 13.85% to -$28.9 million in 2025, then surged by 87.38% to -$3.6 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$3.6 million, -$28.9 million, and -$18.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Geron | 846,759.37 | 846,759.37 | - | -3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.64 Mn |
| Dec 31, 2025 | -28.86 Mn |
| Sep 30, 2025 | -18.43 Mn |
| Jun 30, 2025 | -16.38 Mn |
| Mar 31, 2025 | -19.84 Mn |
| Dec 31, 2024 | -25.35 Mn |
| Sep 30, 2024 | -26.45 Mn |
| Jun 30, 2024 | -67.38 Mn |
| Mar 31, 2024 | -55.39 Mn |
| Dec 31, 2023 | -51.97 Mn |
| Sep 30, 2023 | -44.81 Mn |
| Jun 30, 2023 | -49.23 Mn |
| Mar 31, 2023 | -38.12 Mn |
| Dec 31, 2022 | -42.64 Mn |
| Sep 30, 2022 | -41.05 Mn |
| Jun 30, 2022 | -28.12 Mn |
| Mar 31, 2022 | -30.10 Mn |
| Dec 31, 2021 | -32.02 Mn |
| Sep 30, 2021 | -26.70 Mn |
| Jun 30, 2021 | -29.57 Mn |
| Mar 31, 2021 | -27.82 Mn |
| Dec 31, 2020 | -23.79 Mn |
| Sep 30, 2020 | -19.65 Mn |
| Jun 30, 2020 | -15.82 Mn |
| Mar 31, 2020 | -16.36 Mn |
| Dec 31, 2019 | -29.07 Mn |
| Sep 30, 2019 | -15.18 Mn |
| Jun 30, 2019 | -14.24 Mn |
| Mar 31, 2019 | -10.06 Mn |
| Dec 31, 2018 | -7.30 Mn |
| Sep 30, 2018 | -5.60 Mn |
| Jun 30, 2018 | -6.93 Mn |
| Mar 31, 2018 | -7.19 Mn |
| Dec 31, 2017 | -7.43 Mn |
| Sep 30, 2017 | -6.90 Mn |
| Jun 30, 2017 | -6.41 Mn |
| Mar 31, 2017 | -7.18 Mn |
| Dec 31, 2016 | -8.48 Mn |
| Sep 30, 2016 | -3.58 Mn |
| Jun 30, 2016 | -8.64 Mn |
| Mar 31, 2016 | -8.84 Mn |
| Dec 31, 2015 | -8.47 Mn |
| Sep 30, 2015 | 27.19 Mn |
| Jun 30, 2015 | -9.36 Mn |
| Mar 31, 2015 | -9.32 Mn |
| Dec 31, 2014 | -8.95 Mn |
| Sep 30, 2014 | -9.55 Mn |
| Jun 30, 2014 | -8.73 Mn |
| Mar 31, 2014 | -8.44 Mn |
| Dec 31, 2013 | -9.28 Mn |
| Sep 30, 2013 | -8.25 Mn |
| Jun 30, 2013 | -8.95 Mn |
| Mar 31, 2013 | -11.90 Mn |
| Dec 31, 2012 | -15.86 Mn |
| Sep 30, 2012 | -15.95 Mn |
| Jun 30, 2012 | -18.33 Mn |
| Mar 31, 2012 | -18.74 Mn |
| Dec 31, 2011 | -31.85 Mn |
| Sep 30, 2011 | -19.52 Mn |
| Jun 30, 2011 | -21.09 Mn |
| Mar 31, 2011 | -24.39 Mn |
| Dec 31, 2010 | -59.36 Mn |
| Sep 30, 2010 | -18.34 Mn |
| Jun 30, 2010 | -17.03 Mn |